Skip to main content
Top
Published in: Rheumatology International 2/2008

01-12-2008 | Case Report

A case of catastrophic antiphospholipid syndrome presenting with acute respiratory distress syndrome as the initial manifestation

Authors: Kazushi Kinjo, Hiroya Terabe, Megumi Ogawa, Hideki Takeda, Doki Cho, Shinichi Hoshino, Takeshi Miyahira, Mariko Oshiro

Published in: Rheumatology International | Issue 2/2008

Login to get access

Abstract

Antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized by a combination of arterial or venous thrombosis and recurrent fetal loss, accompanied by elevated titers of antiphospholipid antibodies (aPL). Catastrophic antiphospholipid syndrome (CAPS) is a small subset of APS characterized by widespread systemic thrombotic disease with multiorgan failure. We herein describe an autopsy case of CAPS who developed severe respiratory failure due to acute respiratory distress syndrome (ARDS) as the initial manifestation. Patients with APS may exhibit a broad spectrum of pulmonary diseases. ARDS is the common pulmonary complication in CAPS, although it rarely occurs in APS. Some mechanisms of ARDS in CAPS have been postulated but the precise mechanism is still not clearly understood. It is important to understand that APS or CAPS could be a cause of ARDS since ARDS might develop as the initial manifestation of APS or CAPS as seen in our case. Our case is interesting in that severe respiratory failure due to ARDS was the initial presentation of CAPS.
Literature
2.
go back to reference Cervera R, Asherson RA, Font J (2006) Catastrophic antiphospholipid syndrome. Rheum Dis Clin North Am 32:575–590PubMedCrossRef Cervera R, Asherson RA, Font J (2006) Catastrophic antiphospholipid syndrome. Rheum Dis Clin North Am 32:575–590PubMedCrossRef
3.
go back to reference Bucciarelli S, Espinosa G, Asherson RA et al (2006) The acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47 patients. Ann Rheum Dis 65:81–86PubMedCrossRef Bucciarelli S, Espinosa G, Asherson RA et al (2006) The acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47 patients. Ann Rheum Dis 65:81–86PubMedCrossRef
4.
go back to reference Avcin T, Cimaz R, Meroni PL (2002) Recent advances in antiphospholipid antibodies and antiphospholipid syndromes in pediatric populations. Lupus 11:4–10PubMedCrossRef Avcin T, Cimaz R, Meroni PL (2002) Recent advances in antiphospholipid antibodies and antiphospholipid syndromes in pediatric populations. Lupus 11:4–10PubMedCrossRef
5.
go back to reference Tektonidou MG, Varsou N, Kotoulas G et al (2006) Cognitive deficits in patients with antiphospholipid syndrome. Arch Intern Med 166:2278–2284PubMedCrossRef Tektonidou MG, Varsou N, Kotoulas G et al (2006) Cognitive deficits in patients with antiphospholipid syndrome. Arch Intern Med 166:2278–2284PubMedCrossRef
6.
go back to reference Asherson RA, Liote F, Page B et al (1993) Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus. J Rheumatol 20:284–288PubMed Asherson RA, Liote F, Page B et al (1993) Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus. J Rheumatol 20:284–288PubMed
7.
go back to reference Espinosa G, Santos E, Cervera R et al (2003) Adrenal involvement in the antiphospholipid syndrome: clinical and immunologic characteristics of 86 patients. Medicine (Balt) 82:106–118CrossRef Espinosa G, Santos E, Cervera R et al (2003) Adrenal involvement in the antiphospholipid syndrome: clinical and immunologic characteristics of 86 patients. Medicine (Balt) 82:106–118CrossRef
8.
go back to reference Espinosa G, Cervera R, Font J et al (2002) The lung in the antiphospholipid syndrome. Ann Rheum Dis 61:195–198PubMedCrossRef Espinosa G, Cervera R, Font J et al (2002) The lung in the antiphospholipid syndrome. Ann Rheum Dis 61:195–198PubMedCrossRef
9.
go back to reference Asherson RA, Higenbottam TW, Dinh Xuan AT et al (1990) Pulmonary hypertension in a lupus clinic: experience with twenty-four patients. J Rheumatol 17:1292–1298PubMed Asherson RA, Higenbottam TW, Dinh Xuan AT et al (1990) Pulmonary hypertension in a lupus clinic: experience with twenty-four patients. J Rheumatol 17:1292–1298PubMed
10.
go back to reference Ghosh S, Walters HD, Joist JH, Osborn TG et al (1993) Adult respiratory distress syndrome associated with antiphospholipid antibody syndrome. J Rheumatol 20:1406–1408PubMed Ghosh S, Walters HD, Joist JH, Osborn TG et al (1993) Adult respiratory distress syndrome associated with antiphospholipid antibody syndrome. J Rheumatol 20:1406–1408PubMed
11.
12.
go back to reference Tomashefski JF Jr (1990) Pulmonary pathology of the adult respiratory distress syndrome. Clin Chest Med 11:593–619PubMed Tomashefski JF Jr (1990) Pulmonary pathology of the adult respiratory distress syndrome. Clin Chest Med 11:593–619PubMed
13.
go back to reference Vianna JL, Khamashta MA, Ordi-Ros J et al (1994) Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients. Am J Med 96:3–9PubMedCrossRef Vianna JL, Khamashta MA, Ordi-Ros J et al (1994) Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients. Am J Med 96:3–9PubMedCrossRef
14.
go back to reference Hojnik M, George J, Ziporen L et al (1996) Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation 93:1579–1587PubMed Hojnik M, George J, Ziporen L et al (1996) Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation 93:1579–1587PubMed
15.
go back to reference Nochy D, Daugas E, Droz D et al (1999) The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol 10:507–518PubMed Nochy D, Daugas E, Droz D et al (1999) The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol 10:507–518PubMed
16.
go back to reference Nakos G, Kitsiouli E, Maneta-Peyret L et al (2001) The characteristics of bronchoalveolar lavage from a patient with antiphospholipid syndrome who develop acute respiratory distress syndrome. Clin Rheumatol 20:91–97PubMedCrossRef Nakos G, Kitsiouli E, Maneta-Peyret L et al (2001) The characteristics of bronchoalveolar lavage from a patient with antiphospholipid syndrome who develop acute respiratory distress syndrome. Clin Rheumatol 20:91–97PubMedCrossRef
17.
go back to reference Belmont HM, Abramson SB, Lie JT (1996) Pathology and pathogenesis of vascular injury in systemic lupus erythematosus. Interactions of inflammatory cells and activated endothelium. Arthritis Rheum 39:9–22PubMedCrossRef Belmont HM, Abramson SB, Lie JT (1996) Pathology and pathogenesis of vascular injury in systemic lupus erythematosus. Interactions of inflammatory cells and activated endothelium. Arthritis Rheum 39:9–22PubMedCrossRef
18.
go back to reference Ingram SB, Goodnight SH, Bennett RM (1987) An unusual syndrome of a devastating non-inflammatory vasculopathy associated with anticardiolipin antibodies. Report of two cases. Arthritis Rheum 30:1167–1172PubMedCrossRef Ingram SB, Goodnight SH, Bennett RM (1987) An unusual syndrome of a devastating non-inflammatory vasculopathy associated with anticardiolipin antibodies. Report of two cases. Arthritis Rheum 30:1167–1172PubMedCrossRef
19.
go back to reference Kerr JE, Poe R, Kramer Z (1997) Antiphospholipid antibody syndrome presenting as a refractory noninflammatory pulmonary vasculopathy. Chest 112:1707–1710PubMedCrossRef Kerr JE, Poe R, Kramer Z (1997) Antiphospholipid antibody syndrome presenting as a refractory noninflammatory pulmonary vasculopathy. Chest 112:1707–1710PubMedCrossRef
Metadata
Title
A case of catastrophic antiphospholipid syndrome presenting with acute respiratory distress syndrome as the initial manifestation
Authors
Kazushi Kinjo
Hiroya Terabe
Megumi Ogawa
Hideki Takeda
Doki Cho
Shinichi Hoshino
Takeshi Miyahira
Mariko Oshiro
Publication date
01-12-2008
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 2/2008
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-008-0649-x

Other articles of this Issue 2/2008

Rheumatology International 2/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.